Indinavir Sulfate

硫酸茚地那韦

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIndinavir Sulfate
Drug Alias NameIndinavirum硫酸英地那韦硫酸印地那韦茚地那韦佳息患 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman immunodeficiency virus type 1 protease inhibitors
TargetsHuman immunodeficiency virus type 1 protease
Therapy Area/IndicationsRhabdomyosarcomaSarcoma, EwingAcquired Immunodeficiency Syndrome +[4] 
Global Approved IndicationsHIV Infections
Approved Indications in ChinaHIV Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1996/03/13
Country/TerritoryUnited StatesEUMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme CorpMerck & Co Inc
Inactive CompaniesMerck Sharp & Dohme BvNational Cancer InstituteMerck Sharp & Dohme LLC
Active IndicationsHIV Infections
Inactive IndicationsRhabdomyosarcomaSarcoma, EwingAcquired Immunodeficiency Syndrome

Other Information

ATC CodeJ05AE02
Related LinksWikipediaDrugBankKEGG